{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:04:05Z","timestamp":1779685445832,"version":"3.53.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Roux-en-Y gastric bypass (RYGB) rapidly improves glycemic control in obesity and type 2 diabetes (T2D), but the underlying mechanisms remain incompletely understood. Chymotrypsin-like elastase family member 2A (CELA2A), a circulating pancreatic serine protease implicated in metabolic regulation, has been proposed to contribute to these effects, although its regulation in obesity and after metabolic surgery remains unclear. We investigated CELA2A expression in gastrointestinal tissues and circulation in relation to obesity and RYGB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gastric biopsies were collected in a cross-cohort, non-paired comparison perioperatively from patients undergoing sleeve gastrectomy and postoperatively from patients after RYGB. Jejunal biopsies and serum samples were obtained in paired study setup before and after RYGB. Intestinal tissue and serum were also analyzed in mice fed a control or high-fat diet. CELA2A expression was assessed using Western blot, immunohistochemistry, and ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After RYGB, CELA2A expression increased in gastric mucosa but decreased in the jejunum, accompanied by reduced circulating CELA2A. Before surgery, jejunal CELA2A levels were positively associated with HbA1c, but not with fasting insulin. In high-fat diet\u2013fed mice, jejunal CELA2A expression was increased, whereas gastric expression was reduced. Circulating CELA2A levels were not significantly altered in this model. In both species, CELA2A immunoreactivity was observed in mucosal glandular structures of the stomach and jejunum; however, detailed cellular localization in human tissue was not established, and circulating and tissue levels were not directly correlated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CELA2A exhibits tissue-specific regulation in obesity and following bariatric surgery and may represent a candidate component of gastrointestinal metabolic signaling. Further studies are required to define its cellular origin and functional role in glucose homeostasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1833946","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:46:28Z","timestamp":1779684388000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling"],"prefix":"10.3389","volume":"17","author":[{"given":"Carl I. W.","family":"Larson","sequence":"first","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Aluia","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sch\u00e9le","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casselbrant","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Wallenius","sequence":"additional","affiliation":[{"name":"Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"Region V\u00e4stra G\u00f6taland, Department of Surgery, Sahlgrenska University Hospital \u00d6stra","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15807","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Piche","year":"2020","journal-title":"Circ Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2002449","article-title":"Life expectancy after bariatric surgery in the Swedish Obese Subjects Study","volume":"383","author":"Carlsson","year":"2020","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/sa.0b013e31827f316e","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes","volume":"30","author":"Laferrere","year":"2007","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199509000-00011","article-title":"Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus","volume":"222","author":"Pories","year":"1995","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000224726.61448.1b","article-title":"The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes","volume":"244","author":"Rubino","year":"2006","journal-title":"Ann Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-017-3061-3","article-title":"Glycemic control after sleeve gastrectomy and Roux-En-Y gastric bypass in obese subjects with type 2 diabetes mellitus","volume":"28","author":"Wallenius","year":"2018","journal-title":"Obes Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ecl.2022.06.003","article-title":"Physiology reconfigured: How does bariatric surgery lead to diabetes remission","volume":"52","author":"Albaugh","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1307","article-title":"Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass","volume":"63","author":"Bojsen-Moller","year":"2014","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2556-7","article-title":"Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass","volume":"55","author":"Dirksen","year":"2012","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0433","article-title":"Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution","volume":"89","author":"Cummings","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25243","DOI":"10.1038\/s41598-025-10114-x","article-title":"Novel insights on remnant stomach following Roux-en-Y gastric bypass surgery based on histological evaluation and quantitative proteomics analysis","volume":"15","author":"Larson","year":"2025","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/bi00656a036","article-title":"Purification and characterization of two human pancreatic elastases","volume":"15","author":"Largman","year":"1976","journal-title":"Biochemistry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a122204","article-title":"Molecular cloning and expression in Escherichia coli of a cDNA encoding human pancreatic elastase 2","volume":"102","author":"Shirasu","year":"1987","journal-title":"J Biochem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0470-3","article-title":"CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation","volume":"51","author":"Esteghamat","year":"2019","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00018-024-05220-4","article-title":"Update in genetic and epigenetic causes of hypertension","volume":"81","author":"Mani","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1833946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:46:32Z","timestamp":1779684392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1833946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1833946"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1833946","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"1833946"}}